CATALYST PHARMACEU financial statements, including revenue, expenses, profit, and loss

The total revenue of CN2 for the last quarter is 88.87 M CHF, and it's 4.54% lower compared to the previous quarter. The net income of Q1 24 is 21.00 M CHF.